GP78-1 inhibitors represent a specific chemical class of compounds designed to target the protein GP78-1, also known as RNF45. GP78-1 is an E3 ubiquitin ligase responsible for regulating protein quality control and degradation processes within the cell. Inhibiting GP78-1 activity is an area of active research to gain insights into the molecular pathways that govern protein degradation. These inhibitors are meticulously developed to interact with GP78-1 at a molecular level, with the aim of modulating its enzymatic function. By specifically disrupting GP78-1's activity, researchers seek to elucidate its role in cellular protein homeostasis and degradation.
The chemical structures of GP78-1 inhibitors can vary, and they are designed to interact with specific binding sites or domains of GP78-1, thus interfering with its ability to tag proteins for degradation. Investigating GP78-1 inhibitors is an essential endeavor to advance our understanding of the complex cellular mechanisms that govern protein turnover and ensure cellular integrity. Such research contributes to the broader knowledge of cellular processes and their regulation, with implications for various biological and disease-related contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Eeyarestatin I | 412960-54-4 | sc-358130B sc-358130 sc-358130A sc-358130C sc-358130D sc-358130E | 5 mg 10 mg 25 mg 50 mg 100 mg 500 mg | $114.00 $203.00 $354.00 $697.00 $1363.00 $5836.00 | 12 | |
This compound inhibits ERAD by interfering with p97/VCP, a key component in the pathway where GP78 is involved. | ||||||
Stat3 Inhibitor VI, S3I-201 | 501919-59-1 | sc-204304 | 10 mg | $151.00 | 104 | |
This UBE2N inhibitor can disrupt ubiquitin-conjugating activity, indirectly affecting GP78 function. | ||||||
Clotrimazole | 23593-75-1 | sc-3583 sc-3583A | 100 mg 1 g | $42.00 $57.00 | 6 | |
Known as a p97/VCP ATPase inhibitor, Clotrimazole could influence GP78-mediated ERAD processes. | ||||||
DBeQ | 177355-84-9 | sc-499943 | 10 mg | $330.00 | 1 | |
DBeQ is a selective p97/VCP inhibitor, potentially impacting the ERAD pathway where GP78 operates. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that might affect downstream processes of GP78's ubiquitin ligase activity. | ||||||
NMS-873 | 1418013-75-8 | sc-478803 | 5 mg | $300.00 | ||
A potent p97/VCP inhibitor, NMS-873 could indirectly affect GP78's function in ERAD. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
A proteasome inhibitor, affecting the ubiquitin-proteasome pathway, thereby indirectly influencing GP78. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Another proteasome inhibitor, potentially impacting the pathway involving GP78. | ||||||